Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTorotrak PLC Regulatory News (TRK)

  • There is currently no data for TRK

Interim Management Statement

31 Jul 2014 07:00

RNS Number : 8084N
Torotrak PLC
31 July 2014
 



31 July 2014

 

Torotrak plc

("Torotrak", the "Company" or the "Group")

 

Interim Management Statement

 

Torotrak (LSE: TRK) today publishes its Interim Management Statement for the period from 1 April 2014 to 30 July 2014, which includes the trading update to be delivered today at the Company's Annual General Meeting.

 

Since the start of the current financial year the Company has made good progress in relation to the objectives published in the December 2013 Prospectus and the 2014 Annual Report.

 

Our key strategic objectives remain to:

1. Achieve a successful, earlier to market launch of Flybrid KERS in commercial vehicle applications, beginning with buses, where fleet trials are due to commence later this year;

2. Establish low volume manufacturing capability to support high unit value supply of products and to build growing product revenues commencing in the next financial year;

3. Introduce high profile, low volume show cases of our technology for launch in the next three years, which also contribute to product development for next stage higher volume applications; and

4. Establish Tier 1, licensed manufacturing partnerships for volume launch of our products in the critical period: 2017 - 2019, ahead of the next wave of passenger car and commercial vehicle platforms requiring next generation, low CO2 technology.

 

Since the start of the financial year on 1 April 2014, good progress has been made in relation to all of these objectives:

 

Flybrid KERS in commercial vehicles

· The first KERS installation in a Wrightbus StreetLite bus has demonstrated good driveability and energy capture during on road testing in Leyland during July 2014;

· We are now conducting calibration and performance optimisation with the bus powertrain and vehicle operating strategy prior to the next stage testing at Millbrook;

· The Company is on track to commence KERS trials in a bus on a public route with Arriva in Q3 2014;

· We are building a strong pipeline of potential sales opportunities for KERS in buses and considerable interest is being shown in the technology; and

· A funded programme with JCB is underway to design, develop and make Flybrid technology ready for production in excavators, building on successful trials of a prototype design in 2013.

 

Manufacturing capability

· Flywheels and flywheel assembly component manufacturing is scaling up in the Leyland facility to support wider bus fleet trials scheduled for Q1 2015 and expected start of commercial production by end 2015;

· Positive responses to requests to tender have been received from supply chain partners, confirming the bill of material costs for commercial production of KERS units for buses is within target; and

· We are in advanced stages of discussion with key partners for sub-system supply of KERS for buses.

 

Lower volume showcases of technology & product development

· We have commenced a funded programme with Lotus Cars, announced in February this year, integrating KERS into the manual transmission of a performance passenger car.

 

Tier 1 Manufacturing partnerships

· The next stage engineering programme with Allison is underway and on track to receive a success related £1m deferred license fee in Q4 2014; and

· Collaboration with a Tier 1 and global passenger car OEM to optimise V-Charge for new engine platform is progressing well.

 

There is continued, strong business development engagement with OEMs, Tier 1s, and Tier 2s across each product area and in a number of major automotive territories. This has been reflected in terms of six new evaluations and three expressions of volume requirement subject to manufacturer engagement. Our estimate of minimum development time to market is approximately three years, meaning that to achieve our objectives, Tier 1s need to be signed up between this financial year and the financial year ending March 2016. 

 

Jeremy Deering, Chief Executive commented; "Six months after the acquisition of Flybrid and the fund raise, I am delighted to see the market opportunities opening up for us in the way we predicted. The strength of the two organisations, and the breadth of our CO2 reducing technologies, is creating much deeper and urgent engagement with OEMs and Tier 1s than ever before. The new team has great confidence in achieving the objectives as outlined to Shareholders at the time of the Flybrid acquisition."

 

For more information, please visit www.torotrak.com or contact:

 

Torotrak plc

Jeremy Deering, Chief Executive / Rex Vevers, Finance Director

Tel: +44 1772 900931

Charles Stanley Securities (financial adviser and joint broker to Torotrak)

Marc Milmo / Karri Vuori / Carl Holmes

Tel: +44 20 7149 6000

N+1 Singer (joint broker to Torotrak)

Andrew Craig / Ben Wright

Tel: +44 20 7496 3000

Tavistock Communications (financial PR)

Simon Hudson / Lulu Bridges / James Collins

Tel: +44 20 7920 3150

 

Notes to Editors

Torotrak is a leading developer and supplier of variable drive transmission, engine boosting and kinetic energy recovery systems for vehicles. Our portfolio of technology solutions substantially improves fuel economy and reduces CO2 emissions in vehicles through harnessing the power of supercharging to enable engine downsizing, capturing and recycling energy that would otherwise be lost and managing the engine at the optimum point.

 

-ends-

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSRMMMTMBAJTBI
Date   Source Headline
5th Sep 20114:35 pmRNSPrice Monitoring Extension
29th Jul 20113:50 pmRNSResult of AGM
29th Jul 20119:40 amRNSTotal Voting Rights
29th Jul 20117:00 amRNSInterim Management Statement
26th Jul 20117:00 amRNSAnnual Information Update
26th Jul 20117:00 amRNSBlocklisting Interim Review
5th Jul 20114:33 pmRNSPublication of Annual Report and Accounts
7th Jun 20112:49 pmRNSHolding(s) in Company
2nd Jun 20113:52 pmRNSDirector/PDMR Shareholding
2nd Jun 201110:02 amRNSTotal Voting Rights
27th May 20119:17 amRNSDirector/PDMR Shareholding
25th May 20117:00 amRNSFinal Results
11th May 201110:53 amRNSNotice of Results
3rd May 20117:00 amRNSAppointment of John Weston as Chairman
13th Apr 20117:00 amRNSFurther commitment by Allison Transmission, Inc.
15th Feb 20112:30 pmRNSBlocklisting Application
2nd Feb 20117:00 amRNSIMS and Restructuring
26th Jan 20116:11 pmRNSIssue of Equity - Amendment
26th Jan 201110:53 amRNSBlocklisting Interim Review
26th Jan 201110:51 amRNSIssue of Equity
7th Jan 20117:00 amRNSConclusion of agreements re Infinitrak
20th Dec 20103:06 pmRNSDirector/PDMR Shareholding
23rd Nov 20107:00 amRNSHalf Yearly Report
16th Nov 20107:00 amRNSChange of Adviser
29th Jul 20102:17 pmRNSResult of AGM
29th Jul 201011:30 amRNSAGM and IMS Statement
25th May 20107:00 amRNSFinal Results
13th May 20107:00 amRNSInvestment and Joint Venture
22nd Mar 20107:00 amRNSDirector/PDMR Shareholding
18th Mar 20107:00 amRNSLicence Payment
16th Feb 20107:00 amRNSInterim Management Statement
14th Jan 20104:11 pmRNSDirectors' Shareholdings
5th Jan 20105:06 pmRNSTotal Voting Rights
24th Nov 20097:00 amRNSHalf Yearly Report
11th Nov 20099:34 amRNSBlocklisting Application
4th Sep 200911:34 amRNSDirector/PDMR Shareholding
29th Jul 200912:31 pmRNSResult of AGM
28th Jul 200912:30 pmRNSAGM and Interim Management Statement
17th Jun 20099:08 amRNSHolding(s) in Company
27th May 20097:00 amRNSFinal Results
25th Mar 20092:45 pmRNSHolding(s) in Company
20th Mar 20092:10 pmRNSHolding(s) in Company
19th Mar 20099:24 amRNSHolding(s) in Company
17th Mar 20097:00 amRNSNew Licence and Share Issue
10th Mar 20094:01 pmRNSHolding(s) in Company
23rd Feb 20092:23 pmRNSHolding(s) in Company
19th Feb 200910:34 amRNSHolding(s) in Company
16th Feb 20097:00 amRNSInterim Management Statement
4th Feb 20099:14 amRNSHolding(s) in Company
27th Jan 20094:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.